The clinical trials industry is known for it’s extensive use of acronyms, which can often be confusing for those not familiar with the field. With numerous regulatory bodies, organizations, and medical terms, it’s no wonder that the industry has a vast array of acronyms. These are used to describe everything from medical conditions to regulatory documents to save time and simplify communication.

GPT can read and understand how to utilize any well-documented modern API. It also gives users the ability to train the learning model on new specialized or niche interactions. GPT understands FHIR. How far are we, really, from a fine-tuned GPT model analyzing health data to produce its own research insights, or assisting physicians in the analysis of medical images?